Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 29 May 2026 for Exelixis, INC..
Filing timeline
BuySaleJulie Smith
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Julie Smith: trading record in brief
Filings by Julie Smith span 2 companies, the busiest being Exelixis, Inc. and Raptor Pharmaceutical Corp. Over a trading history stretching from 9 February 2016 to 27 May 2026, the count stands at 22 filings.
On the market, this insider has only sold: 6 sales, €7.2M in total. Other entries cover 7 share grants and 6 option exercises. Since January 2026: no purchases and 3 sales on the market.
The record was last updated on 29 May 2026 with a share grant in Exelixis, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Julie Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
8,367 shares0Common StockSEC:0000939767-26-000080:0
42,422 shares@ US$18.1936.4% of flowCommon StockSEC:0000939767-26-000029:0
9,812 shares0Common StockSEC:0000939767-25-000086:0
31,167 shares@ US$20.5053.4% of flowCommon StockSEC:0000939767-25-000045:0
4,682 shares0Common StockSEC:0000939767-24-000129:0
10,015 shares0Common StockSEC:0000939767-24-000094:0
27,280 shares@ US$21.1246.6% of flowCommon StockSEC:0000939767-24-000077:0
16,424 shares0Common StockSEC:0000939767-21-000058:0
64,179 sharesCommon StockSEC:0001140361-16-051872:0
9 of 9 declarations
